THE ROLE OF BEVACIZUMAB IN UVEITIC GLAUCOMA

Sonam A. Bodh et al. Inflammatory glaucoma, 2011 Jan-Apr; 4(1): 3–9, doi:10.4103/0974-620X.77655.

Kalogeropoulos D,, Sung VC. Pathogenesis of Uveitic Glaucoma. J Curr Glaucoma Pract. 2018 Sep-Dec; 12(3): 125–138. doi:10.5005/jp-journals-10028-1257.

26. Ramanan AV,, Dick AD,, Beresford MW. Adalimumab for Uveitis in Juvenile Idiopathic Arthritis. N Engl J Med. 2017 Aug 24;;377((8):):789-–790. doi: 10.1056/NEJMc1708646.

27. Correll CK,, Bullock DR,, Cafferty RM,, et al. Safety of weekly adalimumab in the treatment of juvenile idiopathic arthritis and pediatric chronic uveitis. Clin Rheumatol. 2018 Feb;37(2):549-553. doi: 10.1007/s10067-017-3890-4.

28. Balevic SJ,, Rabinovich CE. Profile of adalimumab and its potential in the treatment of uveitis. Drug Des Devel Ther. 2016 Sep 19;;10::2997-–3003. doi: 10.2147/DDDT.S94188